Alliance for Clinical Trials in Oncology Launches New Multicancer Early Detection Biobank Study

CHICAGO, IL (August 1, 2022) – The Alliance for Clinical Trials in Oncology, in partnership with the National Cancer Institute, part of the National Institutes of Health, today announced the opening of a new study for participant enrollment that aims to obtain a reference set of blood samples from newly diagnosed patients with cancer and healthy individuals without cancer to include in a future study to assess the utility of early cancer detection blood tests.

The Alliance Multicanc


UPCOMING MEETINGS

2022 Fall Hybrid Group Meeting
- November 2-5


All meetings are open to all
Alliance members.
 

TWEETS

FROM THE NCI